American Regent papaverine injection recalled for particulate matter
American Regent's Papaverine HCl Injection (60 mg/2 mL) has been found to contain particulate matter identified as glass and/or paraformaldehyde. The contamination affects one lot (25202, expiring 11/30/2026) distributed nationwide. This is a prescription injectable medication used to treat certain circulatory conditions.
From the FDA notice · Read the official notice ↗ · All American Regent recalls
What to do
- If you have received or administered this medication from lot 25202, do not use it.
- Contact your pharmacy or healthcare provider immediately if you have questions about whether you received an affected batch.
- Report any adverse events or concerns to the FDA MedWatch program or your healthcare provider.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
This recall covers 12 products — see all of them.
Details
- Units affected
- 86,100 vials
- Illnesses reported
- None reported
- Manufactured in
- 5 Ramsay Rd, Shirley, NY, United States
- Classification
- Class I
- Recall number
- D-0800-2026
In the FDA's words
- Description
- Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967. Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde Lot #: 25202, Exp. Date: 11/30/2026. Distribution: Nationwide within the U.S Affected quantity: 86,100 vials
- Hazard
- Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde
12 products in this recall
American Regent injectables recalled for glass and hair contamination
American Regent is recalling 12 injectable and oral solution products, including nitroglycerin, cyanocobalamin (vitamin B12), aminocaproic acid, atropine, acetylcysteine, selenious acid, papaverine, niCARdipine, and the trace element products Multrys and Tralement. Some vials may contain particulate matter identified as hair, glass, and/or paraformaldehyde. No injuries have been reported.
The agency lists each product separately. Check every one you might have.
- Nitroglycerin injection, USP, 50 mg/10 mL (5 mg/mL), packaged in a) 10 mL vials (NDC 0517-4810-01), b) 25x10mL vials (NDC 0517-4810-25) RX only, AMERICAN REG…D-0791-2026 · 98,200 vials
- Cyanocobalamin injection USP, 1,000 mcg/mL, For IM or SC Use Only, packaged in a) 1 mL Multi-Dose Vial (NDC 0517-0031-01), and b) 25x1 mL Multi-Dose Vials (N…D-0792-2026 · 235,350 vials
- Cyanocobalamin injection USP, 10,000 mcg/10 mL (1,000 mcg/mL), For IM or SC Use Only, packaged in a) 10 mL Multi-Dose Vial (NDC 0517-0032-01) and b) 25x10 mL…D-0793-2026 · 26,450 vials
- AMINAOCAPROIC ACID INJECTION, USP, 250 mg/mL (5 g/20 mL), packaged in a) 20 mL MULTIPLE DOSE VIAL FOR IV INFUSION (NDC 0517-9120-01), and b) 25x20 mL MULTIP…D-0794-2026 · 63,200 vials
- Atropine Sulfate injection, USP, 1 mg/mL, For intravenous Use, Sterile, packaged in a) 1 mL Single-Dose Vial (NDC 0517-1001-01), and b) 25x1 mL Single-Dose V…D-0795-2026 · 89,775 vials
- ACETYLCYSTEINE SOLUTION, USP, 10% (100 mg/mL), packaged in a) 4 mL Vial NOT FOR INJECTION (NDC 0517-7504-01), and b) 25x4 mL Vials NOT FOR INJECTION (NDC 051…D-0796-2026 · 316,450 vials
- ACETYLCYSTEINE SOLUTION, USP, 20% (200 mg/mL), packaged in a) 4 mL Vial NOT FOR INJECTION (NDC 0517-7604-01), and b) 25x4 mL Vials NOT FOR INJECTION (NDC 051…D-0797-2026 · 169,200 vials
- Selenious Acid Injection, USP 12 mcg/2 mL (6 mcg/2mL), For intravenous use, packaged in a) 2mL Single-Dose Vial (NDC 0517-6502-01), and b)10x2mL Single-Dose…D-0798-2026 · 41,680 vials
- Multrys (Trace Elements Injection 4, USP), For intravenous infusion, packaged in a) 1 mL Single-Dose Vial (NDC 0517-9302-01), and b) 25x1 mL Single-Dose Vial…D-0799-2026 · 185,775 vials
- Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-… (this page)D-0800-2026 · 86,100 vials
- Tralement (trace elements injection 4*, USP), packaged in a) 1mL Single Dose vials (NDC 0517-9305-01) and b) 5x1mL Single Dose vials (NDC 0517-9305-25), Rx o…D-0801-2026 · 323,000 vials
- niCARdipine Hydrochloride Injection, USP, 25 mg/10mL (2.5 mg/mL), packaged in a) 10 mL Single Dose Vial (NDC 72572-470-01) and b) 10x10 mL Single Dose Vials…D-0802-2026 · 43,460 vials
More from American Regent
See all- American Regent cyanocobalamin injection recalled for cellulose fiber
ModerateFDANov 19, 2026
- American Regent cyanocobalamin injection recalled for glass particles
ModerateFDANov 4, 2026
- American Regent epinephrine injection recalled for particulate matter
SeriousFDASep 16, 2026
